[Corrections] Correction to Lancet Oncol 2017; 18: 1493–501

Tawbi HA, Burgess M, Bolejack V, et al. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol 2017; 18: 1493–501—The appendix of this Article has been updated. This correction has been made to the online version as of Dec 29, 2017.

http://ift.tt/2C9IoNX